KẾT QUẢ ĐIỀU TRỊ CỦA THAI PHỤ TIỀN SẢN GIẬT CÓ DẤU HIỆU NẶNG TẠI BỆNH VIỆN PHỤ SẢN HÀ NỘI

Abstract

Objective: To evaluate the maternal and fetal outcomes in severe pre-eclampsia at Ha Noi Obstetrics and Gynecology Hospital in 2022. Materials and method: A retrospective cross-sectional study included in 125 pregnant women diagnosed with pre-eclampsia at Ha Noi Obstetrics and Gynecology Hospital in 2022. Results: There were a total 125 women with preeclampsia (PE), 96 patients (76.8%) were diagnosed with PE with severe features. Of these, 91.7% were treated with combination therapy for treatment hypertension (two or more antihypertensive drugs). Among those with gestational age under 34 weeks, 76.7% were given antenatal corticosteroids and among those with gestational age under 32 weeks, 59.5% received antenatal Magie sulfate as an infant neuroprotectant. Among these, induction of labor was only 5.2%, 8.3% had spontaneous labor and 86.5% had elective caesarean section, maily due to the complications of preeclampsia. The most common neonatal complication were prematurity (65.6%) and low birth weight (69.8%). Conclusion: Gestational age at the termination of pregnancy improved significantly. Antenatal management and medication treatment will markedly change obstetric outcomes. Prematurity, growth restriction and low birth weight are severe complications to be anticipated appropriately in preeclampsia.